These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35435976)

  • 1. Protective Effect of Intestinal Blautia Against Neutropenic Fever in Allogeneic Transplant Recipients.
    Rashidi A; Peled JU; Ebadi M; Rehman TU; Elhusseini H; Marcello LT; Halaweish H; Kaiser T; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
    Clin Infect Dis; 2022 Nov; 75(11):1912-1920. PubMed ID: 35435976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
    van Lier YF; Vos J; Blom B; Hazenberg MD
    Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
    Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
    Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications.
    Weber D; Hiergeist A; Weber M; Ghimire S; Salzberger B; Wolff D; Poeck H; Gessner A; Edinger M; Herr W; Meedt E; Holler E
    Clin Infect Dis; 2023 Nov; 77(10):1432-1439. PubMed ID: 37386935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.
    Biagi E; Zama D; Rampelli S; Turroni S; Brigidi P; Consolandi C; Severgnini M; Picotti E; Gasperini P; Merli P; Decembrino N; Zecca M; Cesaro S; Faraci M; Prete A; Locatelli F; Pession A; Candela M; Masetti R
    BMC Med Genomics; 2019 Mar; 12(1):49. PubMed ID: 30845942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients.
    Ilett EE; Jørgensen M; Noguera-Julian M; Nørgaard JC; Daugaard G; Helleberg M; Paredes R; Murray DD; Lundgren J; MacPherson C; Reekie J; Sengeløv H
    Blood Adv; 2020 Nov; 4(22):5797-5809. PubMed ID: 33232475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Ramamoorthy S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
    Cancer Res Commun; 2024 Jun; 4(6):1454-1466. PubMed ID: 38767452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series.
    Gray AN; Tobin NH; Moore TB; Li F; Aldrovandi GM
    Int J Med Microbiol; 2023 May; 313(3):151580. PubMed ID: 37121094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease.
    Lee SE; Lim JY; Ryu DB; Kim TW; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Kim CS; Shin DM; Min CK
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1933-1943. PubMed ID: 31195137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
    Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
    Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
    Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
    Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Han L; Zhang H; Chen S; Zhou L; Li Y; Zhao K; Huang F; Fan Z; Xuan L; Zhang X; Dai M; Lin Q; Jiang Z; Peng J; Jin H; Liu Q
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1944-1955. PubMed ID: 31299215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.
    Ramalingam S; Siamakpour-Reihani S; Bohannan L; Ren Y; Sibley A; Sheng J; Ma L; Nixon AB; Lyu J; Parker DC; Bain J; Muehlbauer M; Ilkayeva O; Kraus VB; Huebner JL; Spitzer T; Brown J; Peled JU; van den Brink M; Gomes A; Choi T; Gasparetto C; Horwitz M; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Sung AD
    PLoS One; 2021; 16(6):e0252995. PubMed ID: 34170918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
    Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
    Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.
    Masetti R; Leardini D; Muratore E; Fabbrini M; D'Amico F; Zama D; Baccelli F; Gottardi F; Belotti T; Ussowicz M; Fraczkiewicz J; Cesaro S; Zecca M; Merli P; Candela M; Pession A; Locatelli F; Prete A; Brigidi P; Turroni S
    Blood; 2023 Oct; 142(16):1387-1398. PubMed ID: 37856089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of microbiota-derived protective metabolites after neutropenic fever.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Halaweish H; Holtan SG; Ramamoorthy S; Weisdorf DJ; Khoruts A; Staley C
    Sci Rep; 2022 Apr; 12(1):6244. PubMed ID: 35428797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Nalluri H; Kaiser T; Ramamoorthy S; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
    Blood Adv; 2021 Oct; 5(20):3937-3950. PubMed ID: 34478486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation.
    Bansal R; Park H; Taborda CC; Gordillo C; Mapara MY; Assal A; Uhlemann AC; Reshef R
    Transplant Cell Ther; 2022 Mar; 28(3):135-144. PubMed ID: 34958974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.